Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-05-10
2000-11-21
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514320, A61K 3155, A61K 31445
Patent
active
061503576
ABSTRACT:
This application discloses a method of treating cardiac ventricular arrhythmias and repolarization abnormalities associated with long QT syndrome and/or congestive heart failure comprising the adminstration of an agonist of the slowly activating cardiac delayed rectifier potassium current (I.sub.Ks).
REFERENCES:
patent: 4820834 (1989-04-01), Evans et al.
patent: 5733905 (1998-03-01), Albright et al.
Hondeghem, L.M., Jour. of Cardiovascular Pharmacology, vol. 20 (2), S17-S-22 (1992).
Jurkiewicz, N.K. et al., Circulation Research, vol. 72 (1) (1993).
Roden, D.M., et al., Circulation, vol. 94 (8) pp. 1996-2012 (1996).
Sanguinetti, M.C. et al., Am. J. Physiol 260 (2 Part 2) E393-E399 (1991).
Sanguinetti, M.C. et al., Circulation Research, vol. 68, (1), pp. 77-84 (1991).
Sanguinetti, M.C. et al., The Jour. of General Physiology, vol. 96, pp. 195-215 (1990).
Tomaselli, G.F. et al., Circulation, vol. 90 (5) pp. 2534-2539 (1994).
Jurkiewicz Nancy K.
Salata Joseph J.
Sanguinetti Michael C.
Wang Jixin
Camara Valerie J.
Daniel Mark R.
Henley III Raymond
Merck & Co. , Inc.
LandOfFree
Potassium channel agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potassium channel agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potassium channel agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1257370